

CLASSIFICATION: GROWTH HORMONE RELEASING HORMONE ANALOG & SECRETAGOGUE
ACTIVE SUBSTANCES:
- CJC-1295 5 MG
- IPAMORELIN 5 MG
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE:
- APPROXIMATELY 7-10 DAYS (CJC-1295)
- 2 HOURS (IPAMORELIN)
DOSAGE: 100-300 MCG 1-2 TIMES DAILY
ACNE: RARE
WATER RETENTION: LOW
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE REPORTED
AROMATIZATION: DOES NOT CONVERT TO ESTROGEN
MANUFACTURER: PEPTIDE HUBS
Experience the powerful synergy of two exceptional growth hormone secretagogues with Peptide Hubs' CJC-1295/Ipamorelin 10mg blend. This advanced combination features 5mg of CJC-1295 and 5mg of Ipamorelin, meticulously formulated to maximize growth hormone release while minimizing unwanted side effects. Sourced from our trusted manufacturing facilities, this pharmaceutical-grade peptide complex represents the cutting edge of performance enhancement and body composition optimization.
The strategic combination of CJC-1295 and Ipamorelin creates a powerful synergistic effect that surpasses what either peptide could achieve individually. CJC-1295, a synthetic analog of growth hormone-releasing hormone (GHRH) with Drug Affinity Complex (DAC) technology, binds to albumin in the bloodstream, significantly extending its half-life and providing sustained GH release. Meanwhile, Ipamorelin, a selective growth hormone secretagogue (GHS), works through the ghrelin receptor pathway to amplify pulsatile GH release without affecting cortisol or prolactin levels.
According to research published in the Oxford Academic, combination therapy with long-acting GHRH analogs and GHS peptides can produce sustained increases in IGF-1 levels and pulsatile growth hormone release that closely mimics natural secretion patterns. This scientific foundation makes the CJC-1295/Ipamorelin blend exceptionally effective for athletes seeking optimal body composition changes.
Promotes lean muscle development through increased IGF-1 production and protein synthesis without water retention.
Targets stubborn fat deposits, particularly abdominal fat, by enhancing lipolysis and metabolic rate.
Reduces recovery time between workouts by promoting cellular repair and reducing inflammation.
Enhances deep sleep phases when administered before bedtime, maximizing natural GH pulses and recovery.
For those seeking alternative growth hormone support, consider our Hexarelin which offers powerful GH-releasing effects with a different mechanism of action.
Reconstitute the lyophilized powder with bacteriostatic water before administration. The typical dosage ranges from 100-300 mcg of the combined blend, administered 1-2 times daily. Most users experience optimal results with pre-bedtime administration to coincide with the body's natural nocturnal growth hormone surge. Some athletes benefit from an additional dose upon waking in a fasted state. The extended half-life of CJC-1295 allows for sustained effects between administrations.
For precise dosing, consider pairing with our Sterile Bacteriostatic Water which is specifically formulated for peptide reconstitution and preservation.
Typical cycles range from 8-12 weeks, followed by a 4-week break to prevent desensitization. Many users report noticeable changes in body composition within the first 3-4 weeks, with continued improvements throughout the cycle. For enhanced results, the CJC-1295/Ipamorelin blend can be stacked with other peptides that complement its action.
Consider combining with TB-500 for accelerated injury recovery and enhanced connective tissue support, or with PEG-MGF for targeted muscle growth and repair.
Important: This product is intended for research purposes only. Not for human consumption. Always consult with a healthcare professional before beginning any new supplement regimen.
Our CJC-1295/Ipamorelin combination undergoes rigorous third-party testing to ensure purity, potency, and sterility. Each batch is manufactured in ISO-certified facilities using pharmaceutical-grade ingredients and advanced lyophilization technology. The result is a premium peptide product that delivers consistent, measurable results for serious athletes.
For those interested in other peptide options, explore our Delta Sleep Inducing Peptide (DSIP) for improved sleep quality and stress reduction, or our GHK-Cu Copper Peptide for skin rejuvenation and tissue repair benefits.
Peptide Hubs remains committed to providing the highest quality research peptides to the athletic community. Our CJC-1295/Ipamorelin blend represents the pinnacle of peptide technology, offering a safe, effective alternative to traditional growth hormone therapy without the associated risks or prohibitive costs.
CJC-1295 features Drug Affinity Complex (DAC) technology that allows it to bind to albumin in the bloodstream, significantly extending its half-life to approximately 7-10 days. This creates sustained growth hormone release between administrations, unlike shorter-acting GHRH analogs that require more frequent dosing. The DAC modification also enhances stability and bioavailability compared to unmodified GHRH peptides.
The most effective administration time is before bedtime to coincide with your body's natural growth hormone pulse. Many users also benefit from a second dose upon waking in a fasted state. Avoid administering immediately after meals as elevated blood glucose can blunt the growth hormone response. The extended half-life of CJC-1295 means timing is less critical than with shorter-acting peptides, but consistency yields optimal results.
Users typically notice improved sleep quality and enhanced recovery within the first week. Visible fat loss, especially around the abdominal area, becomes apparent within 3-4 weeks. Full cycle results include significantly improved muscle definition, reduced body fat, enhanced recovery, improved skin texture, and increased lean muscle mass. The extended half-life of CJC-1295 provides more consistent results than shorter-acting peptide combinations.
CJC-1295/Ipamorelin is generally well-tolerated. Some users report temporary flushing, lightheadedness, or tingling sensations shortly after injection—these typically subside within 30 minutes. Unlike traditional GH therapy, this blend does not cause water retention, joint pain, or carpal tunnel syndrome. The selective action of Ipamorelin means it doesn't affect cortisol or prolactin levels, minimizing potential side effects.
While both combinations are effective, CJC-1295/Ipamorelin offers extended activity due to the DAC technology in CJC-1295, providing more sustained growth hormone release between doses. Tesamorelin is specifically noted for its potent fat-loss effects, particularly on abdominal fat, while CJC-1295/Ipamorelin may offer more balanced benefits for both muscle growth and fat loss. The choice between them depends on individual goals and response patterns.
Please log in to write CJC 1295/IPAMORELIN 10 MG review.
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (rHGH)
ACTIVE SUBSTANCE: SOMATROPIN
FORM: 1 PRE-FILLED PEN x 36 IU (12 MG)
ACTIVE HALF-LIFE: ~3.5 HOURS (SUBQ)
DOSAGE: 1–4 IU/DAY FOR ANTI-AGING; 4–8 IU/DAY FOR FAT LOSS OR PERFORMANCE
WATER RETENTION: POSSIBLE (DOSE DEPENDENT)
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PFIZER
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (r-hGH)
ACTIVE SUBSTANCE: SOMATROPIN (R-HGH)
FORM: 1 CARTRIDGE x 15 MG
ACTIVE HALF-LIFE: ~2–3 HOURS
DOSAGE: MEN 4-10 IU/DAY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): MAY INCREASE VIA FLUID RETENTION
HEPATOTOXICITY: NONE TYPICAL
AROMATIZATION: NONE
MANUFACTURER: NOVO NORDISK
CLASSIFICATION: GONADOTROPIN (LH RECEPTOR AGONIST)
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 LYOPHILIZED VIAL x 5000 IU + PROVIDED SOLVENT
ACTIVE HALF-LIFE: ~24–36 HOURS
DOSAGE: MEN 500-1000 IU
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): MONITOR IF AT CV RISK
HEPATOTOXICITY: NONE TYPICAL
AROMATIZATION: INDIRECT
MANUFACTURER: IBSA
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 ML AMP x 5000 IU
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: MODERATE
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY ELEVATES ESTROGEN
MANUFACTURER: SUN PHARMA
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: PRE-MIXED HUMAN CHORIONIC GONADOTROPIN
FORM: 1 VIAL x 10000 IU (READY-TO-INJECT)
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: LOW to MODERATE
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY INCREASES ESTROGEN
MANUFACTURER: BHARAT SERUMS AND VACCINES
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: PRE-MIXED HUMAN CHORIONIC GONADOTROPIN
FORM: 1 VIAL x 5000 IU (READY-TO-INJECT)
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: LOW to MODERATE
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY INCREASES ESTROGEN
MANUFACTURER: BHARAT SERUMS AND VACCINES
CLASSIFICATION: NATURAL HORMONE
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 AMP [2 ML PER AMP] x 10000 IU
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3 TIMES/WEEK (ON-CYCLE OR PCT)
ACNE: POSSIBLE
WATER RETENTION: LOW
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NO
AROMATIZATION: INDIRECTLY ELEVATES ESTROGEN
MANUFACTURER: SUN PHARMACEUTICALS
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: POWDER - 2 ML VIAL x 5000 IUS + 1 AMP SOLVENT
ACTIVE HALF-LIFE: ~ 24-36 HOURS
DOSAGE: MEN - 500-1500 IU 2-3 TIMES/WEEK
ACNE: NO
WATER RETENTION: MILD
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS